• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

m6A与程序性细胞死亡在心血管疾病中的新兴作用

The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases.

作者信息

Wang Haixia, Han Juanjuan, Kong Hui, Ma Ce, Zhang Xin-An

机构信息

College of Exercise and Health, Shenyang Sport University, Shenyang 110102, China.

College of Exercise and Health, Shanghai Sport University, Shanghai 200438, China.

出版信息

Biomolecules. 2025 Feb 8;15(2):247. doi: 10.3390/biom15020247.

DOI:10.3390/biom15020247
PMID:40001550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11853213/
Abstract

N6-methyladenosine (m6A) is the most prevalent internal chemical modification in eukaryotic messenger RNA (mRNA), significantly impacting its lifecycle through dynamic and reversible processes involving methyltransferase, demethylase, and binding proteins. These processes regulate mRNA stability, splicing, nuclear export, translation, and degradation. Programmed cell death (PCD), a tightly controlled process encompassing apoptosis, pyroptosis, ferroptosis, autophagy, and necroptosis, plays a crucial role in maintaining cellular homeostasis, tissue development, and function. Recently, m6A modification has emerged as a significant research area due to its role in regulating PCD and its implications in cardiovascular diseases (CVDs). In this review, we delve into the intricate relationship between various PCD types and m6A modification, emphasizing their pivotal roles in the initiation and progression of CVDs such as myocardial ischemia-reperfusion (I/R), atherosclerosis (AS), pulmonary hypertension (PH), cardiomyopathy, doxorubicin (Dox)-induced cardiotoxicity (DIC), heart failure (HF), and myocardial infarction (MI). Our findings underscore the potential of elucidating the roles of m6A and PCD in CVD to pave new pathways for prevention and treatment strategies.

摘要

N6-甲基腺苷(m6A)是真核生物信使核糖核酸(mRNA)中最普遍的内部化学修饰,通过涉及甲基转移酶、去甲基酶和结合蛋白的动态可逆过程,对其生命周期产生重大影响。这些过程调节mRNA的稳定性、剪接、核输出、翻译和降解。程序性细胞死亡(PCD)是一个严格控制的过程,包括凋亡、焦亡、铁死亡、自噬和坏死性凋亡,在维持细胞稳态、组织发育和功能方面发挥着关键作用。最近,m6A修饰因其在调节PCD中的作用及其在心血管疾病(CVD)中的意义而成为一个重要的研究领域。在这篇综述中,我们深入探讨了各种PCD类型与m6A修饰之间的复杂关系,强调它们在诸如心肌缺血再灌注(I/R)、动脉粥样硬化(AS)、肺动脉高压(PH)、心肌病、阿霉素(Dox)诱导的心脏毒性(DIC)、心力衰竭(HF)和心肌梗死(MI)等CVD的发生和发展中的关键作用。我们的研究结果强调了阐明m6A和PCD在CVD中的作用为预防和治疗策略开辟新途径的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/886724a244b3/biomolecules-15-00247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/aa5737a67f4c/biomolecules-15-00247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/cbf404f007ab/biomolecules-15-00247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/c7724f94dee8/biomolecules-15-00247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/c010b1230a3d/biomolecules-15-00247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/fe3ba3cbcaf3/biomolecules-15-00247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/886724a244b3/biomolecules-15-00247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/aa5737a67f4c/biomolecules-15-00247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/cbf404f007ab/biomolecules-15-00247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/c7724f94dee8/biomolecules-15-00247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/c010b1230a3d/biomolecules-15-00247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/fe3ba3cbcaf3/biomolecules-15-00247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d280/11853213/886724a244b3/biomolecules-15-00247-g006.jpg

相似文献

1
The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases.m6A与程序性细胞死亡在心血管疾病中的新兴作用
Biomolecules. 2025 Feb 8;15(2):247. doi: 10.3390/biom15020247.
2
Role of M6a Methylation in Myocardial Ischemia-Reperfusion Injury and Doxorubicin-Induced Cardiotoxicity.m6A 甲基化在心肌缺血再灌注损伤和多柔比星致心肌毒性中的作用。
Cardiovasc Toxicol. 2024 Sep;24(9):918-928. doi: 10.1007/s12012-024-09898-7. Epub 2024 Jul 18.
3
Insights into N6-methyladenosine and programmed cell death in cancer.N6-甲基腺苷与癌症中的细胞程序性死亡研究进展
Mol Cancer. 2022 Jan 28;21(1):32. doi: 10.1186/s12943-022-01508-w.
4
m6A control programmed cell death in cardiac fibrosis.m6A 调控心肌纤维化中的细胞死亡。
Life Sci. 2024 Sep 15;353:122922. doi: 10.1016/j.lfs.2024.122922. Epub 2024 Jul 18.
5
Insights into RNA N6-methyladenosine and programmed cell death in atherosclerosis.RNA N6-甲基腺苷与动脉粥样硬化中程序性细胞死亡的研究进展
Mol Med. 2024 Sep 3;30(1):137. doi: 10.1186/s10020-024-00901-z.
6
Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.m6A 甲基化在心脏代谢疾病中的新兴作用和机制。
Cells. 2022 Mar 24;11(7):1101. doi: 10.3390/cells11071101.
7
Novel insights into the interplay between m6A modification and programmed cell death in cancer.新型见解揭示 m6A 修饰与癌症中程序性细胞死亡的相互作用。
Int J Biol Sci. 2023 Mar 13;19(6):1748-1763. doi: 10.7150/ijbs.81000. eCollection 2023.
8
N(6)-methyladenosine modification: A vital role of programmed cell death in myocardial ischemia/reperfusion injury.N(6)-甲基腺苷修饰:细胞程序性死亡在心肌缺血/再灌注损伤中的重要作用。
Int J Cardiol. 2022 Nov 15;367:11-19. doi: 10.1016/j.ijcard.2022.08.042. Epub 2022 Aug 21.
9
Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system.N6-甲基腺苷(m6A)RNA 甲基化在心血管系统中的表观遗传作用。
J Zhejiang Univ Sci B. 2020 Jul;21(7):509-523. doi: 10.1631/jzus.B1900680.
10
Alkbh5 promotes Ythdf1 expression through demethylation thereby facilitating Fth1 translation to inhibit ferroptosis of myocardial infarction.Alkbh5通过去甲基化促进Ythdf1表达,从而促进Fth1翻译以抑制心肌梗死的铁死亡。
BMC Cardiovasc Disord. 2025 Apr 18;25(1):295. doi: 10.1186/s12872-025-04749-x.

引用本文的文献

1
Circular RNAs modulate cell death in cardiovascular diseases.环状RNA在心血管疾病中调节细胞死亡。
Cell Death Discov. 2025 May 2;11(1):214. doi: 10.1038/s41420-025-02504-x.
2
Alkbh5 promotes Ythdf1 expression through demethylation thereby facilitating Fth1 translation to inhibit ferroptosis of myocardial infarction.Alkbh5通过去甲基化促进Ythdf1表达,从而促进Fth1翻译以抑制心肌梗死的铁死亡。
BMC Cardiovasc Disord. 2025 Apr 18;25(1):295. doi: 10.1186/s12872-025-04749-x.

本文引用的文献

1
Methyltransferase-Like 3-Mediated N6-Methyladenosine RNA Methylation Regulates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Pyroptosis by Targeting PTEN.甲基转移酶样蛋白 3 介导的 N6-甲基腺苷 RNA 甲基化通过靶向 PTEN 调节低氧诱导的肺动脉平滑肌细胞焦亡。
J Am Heart Assoc. 2024 Oct;13(19):e034470. doi: 10.1161/JAHA.124.034470. Epub 2024 Sep 30.
2
Methyltransferase METTL3 governs the modulation of SH3BGR expression through m6A methylation modification, imparting influence on apoptosis in the context of Down syndrome-associated cardiac development.甲基转移酶METTL3通过m6A甲基化修饰调控SH3BGR的表达,在唐氏综合征相关心脏发育过程中对细胞凋亡产生影响。
Cell Death Discov. 2024 Sep 6;10(1):396. doi: 10.1038/s41420-024-02164-3.
3
Insights into RNA N6-methyladenosine and programmed cell death in atherosclerosis.RNA N6-甲基腺苷与动脉粥样硬化中程序性细胞死亡的研究进展
Mol Med. 2024 Sep 3;30(1):137. doi: 10.1186/s10020-024-00901-z.
4
Leonurine improves atherosclerosis by activating foam cell autophagy and metabolic remodeling via METTL3-mediated AKT1S1 mRNA stability modulation.汉黄芩素通过 METTL3 介导的 AKT1S1 mRNA 稳定性调节,激活泡沫细胞自噬和代谢重编程,改善动脉粥样硬化。
Phytomedicine. 2024 Nov;134:155939. doi: 10.1016/j.phymed.2024.155939. Epub 2024 Aug 11.
5
WTAP promotes fibroblast-like synoviocyte pyroptosis in Rheumatoid arthritis by upregulating N6-methyladenosine modification of NLRP3.WTAP 通过上调 NLRP3 的 N6-甲基腺苷修饰促进类风湿关节炎成纤维样滑膜细胞焦亡。
J Bioenerg Biomembr. 2024 Oct;56(5):563-571. doi: 10.1007/s10863-024-10035-w. Epub 2024 Aug 27.
6
METTL3 restricts RIPK1-dependent cell death via the ATF3-cFLIP axis in the intestinal epithelium.METTL3通过肠道上皮中的ATF3-cFLIP轴限制RIPK1依赖性细胞死亡。
Cell Regen. 2024 Aug 2;13(1):14. doi: 10.1186/s13619-024-00197-8.
7
m6A control programmed cell death in cardiac fibrosis.m6A 调控心肌纤维化中的细胞死亡。
Life Sci. 2024 Sep 15;353:122922. doi: 10.1016/j.lfs.2024.122922. Epub 2024 Jul 18.
8
Role of M6a Methylation in Myocardial Ischemia-Reperfusion Injury and Doxorubicin-Induced Cardiotoxicity.m6A 甲基化在心肌缺血再灌注损伤和多柔比星致心肌毒性中的作用。
Cardiovasc Toxicol. 2024 Sep;24(9):918-928. doi: 10.1007/s12012-024-09898-7. Epub 2024 Jul 18.
9
MA modification in cardiovascular disease: With a focus on programmed cell death.心血管疾病中的甲基化修饰:聚焦于程序性细胞死亡
Genes Dis. 2023 Jul 14;11(5):101039. doi: 10.1016/j.gendis.2023.05.023. eCollection 2024 Sep.
10
YTHDC1 aggravates high glucose-induced retinal vascular endothelial cell injury via m6A modification of CDK6.YTHDC1 通过对 CDK6 的 m6A 修饰加重高糖诱导的视网膜血管内皮细胞损伤。
Biol Direct. 2024 Jul 8;19(1):54. doi: 10.1186/s13062-024-00498-7.